Medicare Enrolled

Dr. Jennifer Ruddy, MD

Pediatric Hematology-Oncology · Seattle, WA
Low-engagement
4800 SAND POINT WAY NE, Seattle, WA 98105
2069872174
In practice since 2009 (17 years)
NPI: 1750518957 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ruddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ruddy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ruddy

Dr. Jennifer Ruddy is a pediatric hematology-oncology specialist in Seattle, WA, with 17 years of NPI registration.

Between the years covered by Open Payments, Dr. Ruddy received a total of $5,701 from 38 pharmaceutical and/or device companies across 310 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric hematology-oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ruddy is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice $5,701 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,701
Total received (2018-2024)
Avg $814/year across 7 years
Top 20% in WA for pediatric hematology-oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
310
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,701 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$676
2023
$794
2022
$695
2021
$803
2020
$557
2019
$1,033
2018
$1,143

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mylan Specialty L.P.
$148
ABBVIE INC.
$103
AstraZeneca Pharmaceuticals LP
$102
VERTEX PHARMACEUTICALS INCORPORATED
$96
Regeneron Healthcare Solutions, Inc.
$69
AIMMUNE THERAPEUTICS, INC.
$45
Genentech USA, Inc.
$40
Philips North America LLC
$21
GENZYME CORPORATION
$20
Baxter Healthcare
$16
Breas Medical, Inc.
$16
Top 3 companies account for 52.2% of 2024 payments
All-time payments by company (2018-2024) ›
Vertex Pharmaceuticals Incorporated
$796
AstraZeneca Pharmaceuticals LP
$652
VERTEX PHARMACEUTICALS INCORPORATED
$587
AbbVie Inc.
$471
Mylan Specialty L.P.
$435
Chiesi USA, Inc.
$430
AbbVie, Inc.
$269
Gilead Sciences, Inc.
$239
ABBVIE INC.
$189
Advanced Respiratory, Inc
$163
Regeneron Healthcare Solutions, Inc.
$149
Allergan Inc.
$147
Genentech USA, Inc.
$96
GlaxoSmithKline, LLC.
$87
GENZYME CORPORATION
$87
Phadia US Inc.
$82
Novartis Pharmaceuticals Corporation
$77
Philips Electronics North America Corporation
$75
CHIESI USA, INC.
$67
Electromed, Inc.
$65
Alcresta Therapeutics, Inc.
$49
Nestle HealthCare Nutrition Inc.
$49
Amgen Inc.
$49
AIMMUNE THERAPEUTICS, INC.
$45
ADVANCED RESPIRATORY, INC
$43
VIVUS, Inc.
$41
Baxter Healthcare
$37
NESTLE HEALTHCARE NUTRITION INC.
$35
PARI Respiratory Equipment, Inc.
$30
Teva Pharmaceuticals USA, Inc.
$24
Philips North America LLC
$21
Pharming Healthcare, Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Shionogi Inc
$18
Breas Medical, Inc.
$16
Insmed, Inc.
$16
Monaghan Medical Corporation
$15
Circassia Pharmaceuticals Inc
$11
Top 3 companies account for 35.7% of all-time payments
Associated products mentioned in payments ›
(8744) Trilogy Evo · (8874) inCourage · (AK6) Vest Therapy · Arikayce · BETHKIS · BRONCHITOL · CREON · Cayston · Creon · DUPIXENT · FASENRA · Fetroja · Hillrom - Vest System Model 105 Home Care · ImmunoCAP · Kitabis Pak · NUCALA · PANCREAZE · PERTZYE · Pulmozyme · QVAR · RELIZORB · RUCONEST · S&RC Und · SMARTVEST · SPIRIVA RESPIMAT · SYMBICORT · SYMDEKO · TEZSPIRE · TOBI · TOBI PODHALER · TOBI Podhaler · TRIKAFTA · TUDORZA PRESSAIR · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · Tobi Podhaler · Vivo 45 LS · XOLAIR · Xolair · ZENPEP · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pediatric hematology-oncology specialist in Seattle?
Compare pediatric hematology-oncologists in the Seattle area by procedure volume, costs, and industry payment transparency.
Browse pediatric hematology-oncologists nearby

Geographic Context

Pediatric hematology-oncologists within 10 mi
21
Per 100K population
0.9
County median income
$122,148
Nearest hospital
SEATTLE CHILDREN'S HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ruddy is a pediatric hematology-oncology specialist, with low-engagement industry engagement in the top 20% of WA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Ruddy receive payments from pharmaceutical companies?
Yes. Dr. Ruddy received a total of $5,701 from 38 companies across 310 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Ruddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatric Hematology-Oncologists in Seattle
Browse pediatric hematology-oncologists in Seattle ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Hematology-Oncologists in WA
Pediatric hematology-oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Hematology-Oncologists in WA
Which WA pediatric hematology-oncologists receive the most from drug and device companies.
By company
Vertex Pharmaceuticals Incorporated Payments to Doctors
See all physicians who received payments from Vertex Pharmaceuticals Incorporated.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
VERTEX PHARMACEUTICALS INCORPORATED Payments to Doctors
See all physicians who received payments from VERTEX PHARMACEUTICALS INCORPORATED.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →